Allix5
🇺🇸Clairity, Inc. · Radiological Software Device To Predict Future Breast Cancer Risk
What it does
Supports the imaging workflow around multi-modality studies — routing, scheduling, or image management — rather than interpreting the images.
Who it's for
Imaging departments and informatics teams managing study flow.
Reported performance
No sensitivity / specificity / AUC was disclosed in the available summary. Many summaries report no standalone metrics — we note that honestly rather than imply a number.
Performance numbers are manufacturer-reported and often single-site; treat them as a starting point, not an independent benchmark.
FDA
EU (CE)
EU coverage is filling out through 2026; absence here doesn't mean a device isn't CE-marked.
Vendor
Cite this page
RadPigeon. "Allix5 (Clairity, Inc.)." AI Devices registry. https://radpigeon.news/ai/device/allix5
Last updated Jun 29, 2026. Information only — not clinical advice. Summaries are RadPigeon's own wording.
